Feasibility study for a novel approach to delivery of breakthrough analgesics in palliative care

Not Applicable

Recruiting

• Conditions: Palliative Care; Breakthrough Pain; Anaesthesiology - Pain management

• Registration Number: ACTRN12622000056796
• Lead Sponsor: Dr Michael Briffa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-01-18
• Last Update Posted: 24 January 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Staff- employed as a Registered Nurse or Medical Officer at Flinders Medical Centre and working at Laurel Hospice

Patients - Admitted patients to the Laurel Hospice receiving intermittent analgesics via subcutaneous or intravenous injection who are over 18.

Exclusion Criteria

Patients not receiving breakthrough analgesia

Patient receiving less than four breakthrough analgesia doses per 24 hours.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pre and post intervention medication audit collected via data extraction of electronic medical records<br>[ Pre intervention is completed <br><br>Post intervention: from time of commencement of intervention to 7 days post-completion of intervention, ];Patient and family will be interviewed to understand their experience (feasibility and usability) using this device. The interview data will be assessed using a descriptive analysis technique. Responses to question will be coded to find common responses, which will be grouped into categories [During intervention and 14 days post intervention ];Staff satisfaction will be assessed using questionnaire software, this will be done automatically through the software Qualtrics. [2 months post completion of intervention. ]

Secondary Outcome Measures

Name	Time	Method
il[Nil]